275 related articles for article (PubMed ID: 16513884)
1. Neuroleptic malignant syndrome related to a switch to perospirone and anticholinergic withdrawal.
Tanii H; Fujita K; Okazaki Y
Am J Psychiatry; 2006 Mar; 163(3):547-8. PubMed ID: 16513884
[No Abstract] [Full Text] [Related]
2. Efficacy of carbamazepine against neuroleptic-induced akathisia in treatment with perospirone: case series.
Masui T; Kusumi I; Takahashi Y; Koyama T
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):343-6. PubMed ID: 15694245
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic malignant syndrome induced by perospirone.
Nakagawa M; Matsumura T; Kato D; Kishida I; Kawanishi C; Tamura K; Hirayasu Y
Int J Neuropsychopharmacol; 2006 Oct; 9(5):635-6. PubMed ID: 16313704
[No Abstract] [Full Text] [Related]
4. [Neuroleptic malignant syndrome--a case report].
Lanczik M; Fritze J
Psychiatr Prax; 1992 May; 19(3):84-6. PubMed ID: 1353269
[TBL] [Abstract][Full Text] [Related]
5. Perospirone in the treatment of patients with delirium.
Takeuchi T; Furuta K; Hirasawa T; Masaki H; Yukizane T; Atsuta H; Nishikawa T
Psychiatry Clin Neurosci; 2007 Feb; 61(1):67-70. PubMed ID: 17239041
[TBL] [Abstract][Full Text] [Related]
6. Effective treatment of coprophagia in a patient with schizophrenia with the novel atypical antipsychotic drug perospirone.
Harada KI; Yamamoto K; Saito T
Pharmacopsychiatry; 2006 May; 39(3):113. PubMed ID: 16721701
[TBL] [Abstract][Full Text] [Related]
7. Two cases of perospirone-induced mania in schizophrenia.
Yokoshima T; Takei N; Tani K; Kawai M; Minabe Y; Mori N
J Clin Psychiatry; 2004 Jan; 65(1):135. PubMed ID: 14974495
[No Abstract] [Full Text] [Related]
8. Perospirone in treatment of Huntington's disease: a first case report.
Roppongi T; Togo T; Nakamura S; Asami T; Yoshimi A; Shiozaki K; Kato D; Kawanishi C; Hirayasu Y
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):308-10. PubMed ID: 16887250
[TBL] [Abstract][Full Text] [Related]
9. Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge.
Gray NS
Hum Psychopharmacol; 2004 Apr; 19(3):205-7. PubMed ID: 15079855
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
[TBL] [Abstract][Full Text] [Related]
11. Clozapine-induced neuroleptic malignant syndrome: clozapine monotherapy rechallenge in a case of previous NMS.
Illing M; Ancill R
Can J Psychiatry; 1996 May; 41(4):258. PubMed ID: 8726793
[No Abstract] [Full Text] [Related]
12. Further observations on the neuroleptic malignant syndrome.
Lazarus A; Lipschutz LB
J Clin Psychopharmacol; 1991 Apr; 11(2):148-9. PubMed ID: 1676039
[No Abstract] [Full Text] [Related]
13. Perospirone. SM 9018.
Drugs R D; 1999 Aug; 2(2):142-3. PubMed ID: 10820662
[No Abstract] [Full Text] [Related]
14. [A case of malignant neuroleptic syndrome with rhabdomyolysis and a therapeutic trial using physostigmine].
Krull F; Risse A
Fortschr Neurol Psychiatr; 1986 Dec; 54(12):398-401. PubMed ID: 2880787
[TBL] [Abstract][Full Text] [Related]
15. A self-limiting case of atypical neuroleptic malignant syndrome associated with zotepine.
Hsu WC; Lin ST; Chen CC; Tsang HY; Huang MF
J Clin Psychopharmacol; 2011 Oct; 31(5):667-9. PubMed ID: 21881455
[No Abstract] [Full Text] [Related]
16. Neuroleptic malignant syndrome following abrupt anti-cholinergic withdrawal: a case report.
Guru S; Vanamoorthy U; Loganathan S; Varghese M
Asian J Psychiatr; 2014 Dec; 12():158-9. PubMed ID: 25440569
[No Abstract] [Full Text] [Related]
17. Use of perospirone for obesity and diabetes mellitus in patients with schizophrenia: three case reports.
Nishida M; Nakamura M
Int Clin Psychopharmacol; 2004 Jan; 19(1):41-3. PubMed ID: 15101570
[TBL] [Abstract][Full Text] [Related]
18. [The neuroleptic malignant syndrome].
Duarte J; García Viejo MA; García Miguel FJ; Sempere AP
Med Clin (Barc); 1994 Oct; 103(14):558. PubMed ID: 7799673
[No Abstract] [Full Text] [Related]
19. Perospirone in the treatment of schizophrenia: effect on verbal memory organization.
Araki T; Yamasue H; Sumiyoshi T; Kuwabara H; Suga M; Iwanami A; Kato N; Kasai K
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):204-8. PubMed ID: 16300872
[TBL] [Abstract][Full Text] [Related]
20. [The risperidone-associated neuroleptic malignant syndrome in a pediatric patient].
Villanueva Lamas J; García García J; Alda Diez JA; Tous Andreu N
An Esp Pediatr; 1998 Dec; 49(6):652-3. PubMed ID: 9972639
[No Abstract] [Full Text] [Related]
[Next] [New Search]
